Agios Pharmaceuticals Inc. Stock
The Agios Pharmaceuticals Inc. stock is trending slightly upwards today, with an increase of €0.20 (0.850%) compared to yesterday's price.
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Agios Pharmaceuticals Inc..
As a result the target price of 37 € shows a very positive potential of 55.46% compared to the current price of 23.8 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 0.850% | 3.509% | 0.000% | -25.786% | 1.724% | -9.231% | -47.532% |
| Iovance Biotherapeutics Inc. | 1.470% | 1.142% | 9.086% | -59.088% | -6.619% | -67.749% | -94.387% |
| United Therapeutics | 1.460% | 2.389% | 1.622% | 14.898% | -4.704% | 70.163% | 182.778% |
| Neurocrine Bioscience | -0.050% | -6.825% | -5.478% | -2.619% | -11.635% | 11.415% | 12.625% |
Comments
Agios Pharmaceuticals (NASDAQ:AGIO) had its price target raised by analysts at HC Wainwright from $62.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $40.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Show more
Ratings data for AGIO provided by MarketBeat
News
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash
On February 17, 2026, Rock Springs Capital Management LP disclosed in an SEC filing that it sold 159,379 shares of Agios Pharmaceuticals (NASDAQ:AGIO) in the fourth quarter, an estimated $5.59
Here's Why Shares in Agios Pharmaceuticals Popped Today
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) soared by more than 18% as of 11 a.m. today. The move follows the company's receipt of approval from the Food and Drug Administration (FDA) for AQVESME
Why Shares in Agios Pharmaceuticals Got Crushed Today
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) crashed by 50% by noontime today. The move comes as the market digests a mixed set of topline results from its Phase 3 trial (RISE UP) of its sickle